OGMBT Banner LSCD22 940x285 ILLU RZ3

Exhibitors

Here an overview of exhibiting companies and institutions at the LIFE SCIENCE CAREER FAIR:

Takeda Hookipa CCRI

Takeda Pharma

HOOKIPA Pharma

St. Anna Children’s Cancer Research Institute (CCRI)

Ribbonbiolabs Boehringer Ingelheim 880x504 Bartelt

Ribbon Biolabs

Boehringer Ingelheim RCV

Bartelt (Labor und Datentechnik)

RCPE SAN Arkeon

Research Center Pharmaceutical Engineering

SAN Group

Arkeon

Phoenestra Evercyte tamirna 880x504

phoenestra

Evercyte

TAmiRNA

 Uni Wien DS  DSM 880x504  acib 880x504

Doctoral School in Microbiology and Environmental Science - University of Vienna

DSM

acib

 euraxess

EURAXESS Austria

 

 

Takeda Pharma

Takeda is a global, values-based, R&D-driven biopharmaceutical leader headquartered in Japan, committed to discover and deliver life-transforming treatments, guided by our commitment to patients, our people and the planet. Takeda focuses its R&D efforts on four therapeutic areas: Oncology, Rare Genetics and Hematology, Neuroscience, and Gastroenterology (GI). We also make targeted R&D investments in Plasma-Derived Therapies and Vaccines.

We are innovators and collaborators with a robust partnership model that is key to bringing forward truly transformative treatments for patients who have significant unmet needs. Our world-class labs are partnered to access cutting-edge science wherever it originates, helping us build one of the most modality-diverse pipelines in the industry. Together, with our investments in data and digital, we aim to revolutionize how we treat disease and improve patients' experiences. We strive to nurture a workplace that is as diverse as the patients we serve; inclusive in our behaviors; and equitable in our actions. Our R&D activities in Austria is a central part of Takeda's global research and development engine. The scope of activities covers the entire pharmaceutical development process, starting with the selection of a product candidate up to the commercialization of the product. The focus is not only on the continuous development or improvement of the manufacturing process, but also on the monitoring of all clinical trials with the aim of ensuring a robust commercial production process.

HOOKIPA Pharma

HOOKIPA Pharma Inc. (NASDAQ: HOOK) is a clinical-stage biopharmaceutical company focused on developing novel immunotherapies that mobilize and amplify targeted T cells to address unmet needs in cancer.

This leveraging its proprietary, versatile platform to engineer a broad pipeline of differentiated arenaviral therapeutics. These novel immunotherapies induce robust antigen-specific killer T cells to a broad range of self and non-self antigens, including viral antigens, tumor-associated antigens and neoantigens. HOOKIPA’s platform technology uses replicating viral vectors based on the target cancer, with the potential to induce killer T cell response levels previously not achieved by other immunotherapy approaches. HOOKIPA’s pipeline includes wholly-owned investigational arenaviral immunotherapeutics targeting HPV16+ cancers, prostate cancer, KRAS-mutated cancers (including colorectal, pancreatic and lung), and other undisclosed projects. In addition, the company aims to develop functional cures of HBV and HIV in collaboration with Gilead.

St. Anna Children’s Cancer Research Institute (CCRI)

CCRI strives to improve treatment for children and adolescents with cancer by bringing together translational and clinical research with open-minded exploration of basic disease mechanisms. Every year, 250-300 children and adolescents in Austria alone are diagnosed with cancer. Thanks to research, more than 80 % of these children will survive. Integrally connected with St. Anna Children’s Hospital, experimental and theoretical scientists at CCRI work side-by-side with oncologists to tackle eminent issues in pediatric cancer research and therapy.

The CCRI trains a generation of passionate and courageous researchers and it hosts state-of-the-art experimental facilities to power it's mission. CCRI tears down conventional boundaries by constant exchange and collaboration with outside institutions for the greater benefit of the patient. Bringing research from bench to bedside, CCRI headquarters clinical trials and is integrated in international networks to maximize innovation and impact.

ribbon Biolabs

Ribbon Biolabs is a synthetic biology company advancing a new technology for the automated synthesis of long DNA molecules to enable innovation in the life sciences. With its proprietary technology in place, Ribbon Biolabs aims to be an inflection point in the continuing growth of the Bio- Economy by becoming the leading partner for long DNA molecules.

Boehringer Ingelheim Regional Center Vienna

Successfully committed to health for over 130 years, Boehringer Ingelheim offers security and stability for its employees. Steady but deliberate growth leads to top solutions for a better life for people and animals.

As part of the German pharmaceutical company Boehringer Ingelheim, the Boehringer Ingelheim Regional Center Vienna (RCV) has business responsibility for over 30 countries in Central and Eastern Europe and Central Asia. This makes the RCV one of the most important locations of the group, with more than 3,000 employees in Vienna.

The Vienna site is the center of cancer research for Boehringer Ingelheim, while one of the most modern biopharmaceutical production facilities in Europe is also in operation here.

Together we are pursuing one goal: to achieve breakthroughs in the treatment of diseases and to advance the development of medicine!

Bartelt (Labor und Datentechnik)

TBA

Research Center Pharmaceutical Engineering

The Research Center Pharmaceutical Engineering (RCPE) is a global leader in pharmaceutical process engineering. The center supports its partners in the development and manufacture of innovative medicines. Our science enables tomorrow's medical discoveries and improves the lives of patients around the world.

With their unique capabilities in simulation, AI, (nano-)material science, process design & quality control, as well as process monitoring and quality assurance, our multinational team redefines what is possible by translating fundamental research into breakthrough industrial applications. As a non-profit, private company owned by Graz University of Technology (65%), the University of Graz (20%), and Joanneum Research GmbH (15%), we combine outstanding science, business, and industry in an application-oriented approach..

SAN Group

SAN Group is a globally operating biotechnology company headquartered in Austria with employees on four continents. We are represented by subsidiaries and distribution partners in Europe, North- and South America, the Middle East, Asia, and Australia. The business of SAN Group focuses on animal health (SAN Vet), plant health (SAN Agrow), and planet health (SAN Venture featuring SAN Real, SAN Enertech, and the winery DER FÖRTHTOF). Or vision is simple as that: Creating science-based solutions for a better tomorrow. SAN Group is 100% privately owned.

 

Arkeon

Arkeon is an Austria-based FoodTech company working to provide the most nutritious and best tasting ingredients for the next generation of alternative protein products. The company’s mission is to decouple food production from agriculture and climate by developing technologies to convert CO2 into complete and versatile protein ingredients such as amino acids and peptides by using gas fermentation. This new way of protein production turns the equation upside down and allows building proteins brick by brick. The technology does not rely on land, animals, or large quantities of water and allows Arkeon to utilize the power of nature to transform a resource-intensive food industry into a sustainable, low-emission system.

 

phoenestra

Phoenestra is a young company focusing on technology platforms enabling the transition of stem cell-derived products into human therapies. We are working on induced pluripotent stem cells - which we generate from cells isolated from human urine samples - and telomerized mesenchymal stromal cells (licensed from Evercyte GmbH) and grow these cell lines under fully controlled conditions in scalable bioreactors. We process these cells further and isolate vesicles derived from stem cells or differentiated cells. Phoenestra is expanding the core team and is currently looking for motivated scientists with cell biology and process science backgrounds.

 

Evercyte

Provision of human cells for biotechnology and biomedicine.
Evercyte makes use of specialized human primary like cells for the development of relevant in vitro test systems that allow the standardization of pre-clinical models. Moreover, our cells are ideal for use as innovative cell factories for production of recombinant complex molecules or extracellular vesicles for clinical applications.

 

TAmiRNA

TAmiRNA is a spin-off of BOKU University and Evercyte GmbH. We launched in 2013 and are still based in Vienna, Austria. Our mission is to discover novel small RNA (microRNA) biomarkers that aid the diagnosis or prognosis of severe human illnesses. We further develop, manufacture, and commercialize the resulting molecular in-vitro-diagnostic tests or offer them as a service. Complementary to our diagnostic business area, we offer RNA biomarker discovery and validation as a fee-for-service to our customers to support basic, translational, and clinical research.

 

University of Vienna - Doctoral School in Microbiology and Environmental Science

The doctoral program at the Doctoral School in Microbiology and Environmental Science is unique in offering interdisciplinary training at the interfaces of microbiology, ecology, and environmental geosciences to address current challenges in the 21st century society, including the role of microbiomes, adaptation and resistance mechanisms, biogeochemistry, pollutant dynamics and nutrient fluxes in global change and for human, animal, plant, and environmental health.During the course of their PhD studies, our students acquire a comprehensive understanding of microbes at all levels, from molecular circuits determining the fate of single cells to microbial communities to ecosystem processes and of pollutant dynamics and nutrient and geochemical cycles.
Students also have access to high-level infrastructure to study microbes, microbe-host interactions, and environmental processes at the forefront of fundamental and applied sciences.

 

DSM

Endless growth. Exciting possibilities.
From your first day with DSM, you’ll be encouraged to discover new things and explore different career paths – guided by strong leadership, provided with incredible resources and given access to our global business. It’s this transformative thinking that helps us find the smart solutions that impact our customers, society and the planet.
The DSM team is made up of a diverse group of people, all working together for the better. We come from all walks of life and bring together different expertise to create a culture that’s caring, courageous and collaborative. It’s a place where you’re supported to be who you are, to put your wellbeing first and to dare to do things differently to create solutions for society.

 

acib

acib is an international centre of excellence in the field of industrial biotechnology. The research centre develops sustainable, environmentally friendly, and economically and technically advanced processes for the biotech-, pharmaceutical- and chemical industries. In doing so, it takes nature’s methods and tools as its model.
Within its partner network, acib cooperates with industry to transfer scientific results into efficient processes and innovative products, always for the benefit of humans, animals and the environment.
The Austrian Centre of Industrial Biotechnology (acib) sees itself as an essential link between research and industry and currently forms a network of about 200 scientific and industrial partners in the field of industrial biotechnology. About 160 scientists in Graz, Vienna, Tulln and Innsbruck are currently working on more than 90 industrial and strategic research projects.
Students also have access to high-level infrastructure to study microbes, microbe-host interactions, and environmental processes at the forefront of fundamental and applied sciences.

 

EURAXESS Austria

Welcome to EURAXESS Austria! EURAXESS is a platform for researchers, entrepreneurs, universities and businesses to interact with each other. Packed with information, EURAXESS covers mobility issues for researchers and entrepreneurs, allows universities and businesses to find the right talent, and connects people, projects and funding. All services of the EURAXESS Network are free of charge.

 

TBA

TBA